Scarica l'app Stockscreener
7.26
0.14%
0.010
Dopo l'orario di chiusura:
7.23
-0.03
-0.41%
Precedente Chiudi:
$7.25
Aprire:
$7.24
Volume 24 ore:
6.10M
Relative Volume:
0.54
Capitalizzazione di mercato:
$2.69B
Reddito:
$3.49M
Utile/perdita netta:
$-663.48M
Rapporto P/E:
-3.243
EPS:
-2.2387
Flusso di cassa netto:
$-115.08M
1 W Prestazione:
+0.14%
1M Prestazione:
+28.04%
6M Prestazione:
+103.36%
1 anno Prestazione:
+81.05%
Intervallo 1D:
$7.23
$7.28
Intervallo di 1 settimana:
$7.21
$7.28
Portata 52W:
$3.265
$7.28
Ataibeckley Inc Stock (ATAI) Company Profile
Nome
Ataibeckley Inc
Settore
Industria
Telefono
1 929 207 2670
Indirizzo
C/O ATAI LIFE SCIENCES US, INC., NEW YORK
Compare ATAI vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
7.26 | 2.68B | 3.49M | -663.48M | -115.08M | -2.2387 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-27 | Iniziato | Deutsche Bank | Buy |
| 2026-01-20 | Iniziato | Guggenheim | Buy |
| 2025-10-13 | Iniziato | Needham | Buy |
| 2025-07-29 | Iniziato | Oppenheimer | Outperform |
| 2024-11-18 | Reiterato | H.C. Wainwright | Buy |
| 2024-04-03 | Aggiornamento | Maxim Group | Hold → Buy |
| 2022-11-01 | Iniziato | Loop Capital | Buy |
| 2021-11-30 | Iniziato | Maxim Group | Buy |
| 2021-11-11 | Iniziato | ROTH Capital | Buy |
| 2021-10-18 | Iniziato | H.C. Wainwright | Buy |
| 2021-09-01 | Iniziato | Jefferies | Buy |
| 2021-07-13 | Iniziato | Berenberg | Buy |
| 2021-07-13 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-13 | Iniziato | Cantor Fitzgerald | Buy |
| 2021-07-13 | Iniziato | Citigroup | Buy |
| 2021-07-13 | Iniziato | Cowen | Outperform |
| 2021-07-13 | Iniziato | Credit Suisse | Outperform |
| 2021-07-13 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Iniziato | Aegis Capital | Buy |
Mostra tutto
Ataibeckley Inc Borsa (ATAI) Ultime notizie
ATAI Beckley earnings beat by $0.03, revenue topped estimates - Investing.com South Africa
CoreWeave To Rally Around 95%? Here Are 10 Top Analyst Forecasts For Wednesday - Sahm
This Apogee Therapeutics Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Sahm
Atai Beckley (NASDAQ:ATAI): What Does the Latest Update Mean for Trial Progress? - Kalkine Media
Deutsche Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $8 - Moomoo
Deutsche Bank Downgrades AtaiBeckley to Hold From Buy, Adjusts PT to $8 From $12 - marketscreener.com
AtaiBeckley Inc. Stock 12‑Month Price Target Cut to $8.83, Implies 22% Upside - TradingView
ATAI SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
AtaiBeckley Inc reports results for the quarter ended June 30Earnings Summary - TradingView
AtaiBeckley (NASDAQ: ATAI) to be acquired by Eli Lilly in $6.75 cash deal plus CVR - Stock Titan
AtaiBeckley Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
ATAI Beckley earnings on deck as investors eye Lilly deal By Investing.com - Investing.com UK
Eli Lilly, AtaiBeckley filed US premerger forms July 29, got German approval July 30 - MLex
AtaiBeckley (NASDAQ: ATAI) backs $6.75 cash sale to Lilly plus CVR upside - Stock Titan
Wall Street Analysts Predict a 31.48% Upside in AtaiBeckley Inc (ATAI): Here's What You Should Know - Yahoo Finance
AtaiBeckley Inc. (ATAI): Investor Outlook with a 33.53% Potential Upside Amid Clinical Innovations - DirectorsTalk Interviews
Tracking Cathie Wood: Adding Intellia and SpaceX, Selling Off AtaiBeckley and Palantir - Moomoo
Are SOLS, LXP, ATAI Obtaining Fair Deals for their Shareholders? - Morningstar
BlackRock, Inc. Adds to AtaiBeckley Inc (ATAI) Stake -- Shares F - GuruFocus
AtaiBeckley Inc. (ATAI) Stock Analysis: Navigating Challenges with a Potential 33.53% Upside - DirectorsTalk Interviews
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet. - Yahoo Finance
ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly - True North Radio Network
BlackRock (ATAI holder) reports 24.99M ATAIBECKLEY shares, a 6.8% position - Stock Titan
AtaiBeckley(ATAI) Stock Options Chain | Quotes & News - Moomoo
Tracking Cathie Wood: Slashing AtaiBeckley and Figma, Betting on Gene-Editor Scribe Therapeutics - Moomoo
ATAI Stock Soars On Eli Lilly’s $2.8B Buyout – Why Are CMPS Shares Rising Too? - Stocktwits
Why Is ATAI Stock Soaring 59% After-Hours? - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – MUN:B72 - TradingView
AtaiBeckley Inc. Revenue Breakdown – FWB:B72 - TradingView
ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly - Stocktwits
AtaiBeckley Inc. Revenue Breakdown – LS:A41WEP - TradingView
Why Did AAPL, ATAI, UNH Stocks Jump To 52-Week Highs Today? - Stocktwits
Is AtaiBeckley (ATAI) A Bargain On Eli Lilly’s Takeover Deal? - simplywall.st
AtaiBeckley Inc. (ATAI) stock price, news, quote and history - Yahoo Finance UK
Form DEF 14A ATAI Beckley Inc For: 23 July By Investing.com - Investing.com Canada
How Much Upside is Left in AtaiBeckley Inc (ATAI)? Wall Street Analysts Think 33.33% - Yahoo Finance
Key facts: Zepbound tops Wegovy; Novo sues; Lilly buys AtaiBeckley - TradingView
Lilly-AtaiBeckley Deal A Stamp Of Approval For Psychedelics - Law360
Are PSNL, LXP, DSGR, ATAI Obtaining Fair Deals for their Shareholders? - TradingView
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal By Investing.com - Investing.com India
H.C. Wainwright downgrades AtaiBeckley stock rating on Lilly deal - Investing.com UK
Tracking Cathie Wood: Backing Prime Medicine and SpaceX, Sells Off AtaiBeckley, Shopify - Moomoo
Eli Lilly Acquires AtaiBeckley to Expand Mental Health Treatment Pipeline in $3.8 Billion Deal - Global Legal Chronicle
AtaiBeckley (NASDAQ:ATAI) shares reflect 18% implied value for acquisition milestone entitlements - TechStock²
ATAIBECKLEY INC : BERENBERG CUTS TO HOLD FROM BUY; CUTS TARGET PRICE TO $7.45 FROM $14 - Bitget
AtaiBeckley (ATAI) H.C. Wainwright 26th Annual Global Investment Conference 2024 summary - Quartr
ATAIBECKLEY INC : TD COWEN CUTS TO HOLD FROM BUY - Bitget
H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5 - Moomoo
J&J, AbbVie said to have also looked at AtaiBeckley before Lilly’s $2.8B deal - Endpoints News
ATAI Stock Downgraded Across Wall Street – Why Analysts Believe Buyout By Eli Lilly Capped Near-Term Upside - TradingView
TD Cowen Downgrades AtaiBeckley to Hold From Buy - Moomoo
Ataibeckley Inc Azioni (ATAI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):